ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,676.36
      0.29%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Guardant Health Inc (GH)

      7. Guardant Health Inc (GH) News

      GH

      Guardant Health (GH)

      Guardant Health Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GH
      DateTimeSourceHeadlineSymbolCompany
      05/31/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
      05/31/20248:05AMBusiness WireGuardant Health Named to TIME100 Most Influential CompaniesNASDAQ:GHGuardant Health Inc
      05/30/20248:05AMBusiness WireGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningNASDAQ:GHGuardant Health Inc
      05/24/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
      05/23/20247:03PMBusiness WireFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionNASDAQ:GHGuardant Health Inc
      05/23/20247:05AMBusiness WireGuardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
      05/22/20244:05PMBusiness WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
      05/21/20248:44AMBusiness WireGuardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnonNASDAQ:GHGuardant Health Inc
      05/21/20248:44AMBusiness WireGuardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-IndikationenNASDAQ:GHGuardant Health Inc
      05/21/20248:05AMBusiness WireGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsNASDAQ:GHGuardant Health Inc
      05/17/20248:05AMBusiness WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
      05/16/20246:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      05/16/20246:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      05/16/20248:05AMBusiness WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekNASDAQ:GHGuardant Health Inc
      05/09/20244:59PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
      05/09/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
      05/09/20244:05PMBusiness WireGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
      05/07/20244:05PMBusiness WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
      05/07/20248:00AMBusiness WireGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneNASDAQ:GHGuardant Health Inc
      05/06/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      05/06/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      05/06/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      04/22/20248:52AMBusiness WireFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23NASDAQ:GHGuardant Health Inc
      04/18/20244:05PMBusiness WireGuardant Health to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:GHGuardant Health Inc
      04/03/20248:05AMBusiness WireGuardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual MeetingNASDAQ:GHGuardant Health Inc
      03/13/20245:00PMBusiness WireGuardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of MedicineNASDAQ:GHGuardant Health Inc
      03/06/20244:30PMBusiness WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
      03/05/20248:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      03/04/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
      03/04/20246:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
       Showing the most relevant articles for your search:NASDAQ:GH

      Your Recent History

      LSE
      WAS
      COIN
      VLTGBP
      KOSPI
      003620
      KG Mobility
      Delayed Upgrade Clock